Preserving Telehealth, Hospital, and Ambulance Access Act, Sec. 105 (Report on Wearable Medical Devices)

Proposed 2024-05-07 | Official source

Summary

Requires the Comptroller General to assess and report on wearable medical devices' capabilities and limitations in clinical decision-making, focusing on AI's benefits and challenges, and proposing policy options to enhance benefits and mitigate challenges.

  • This machine-generated summary is awaiting review by an AGORA editor. Use with caution.

Key facts

๐Ÿ›๏ธ This document was proposed and/or enacted by the United States Congress but is now defunct. For authoritative text and metadata, visit the official source.

๐Ÿ“œ This document's name is Preserving Telehealth, Hospital, and Ambulance Access Act, Sec. 105 (Report on Wearable Medical Devices). It is part of Preserving Telehealth, Hospital, and Ambulance Access Act.

โ†ณ This document is part of a longer one: Preserving Telehealth, Hospital, and Ambulance Access Act. Some AGORA documents are "split off" from longer documents that mix AI and non-AI content, such as omnibus authorization or appropriations laws in the United States Congress. Read more >>

Themes AI risks, applications, governance strategies, and other themes addressed in AGORA documents.

Thematic tags are in progress.

Full text

  • This is an unofficial copy. The document has been archived and reformatted in plaintext for AGORA. Footnotes, tables, and similar material may be omitted. For the official text, visit the original source.
SEC. 105. REPORT ON WEARABLE MEDICAL DEVICES. Not later than 18 months after the date of the enactment of this Act, the Comptroller General of the United States shall conduct a technology assessment of, and submit to Congress a report on, the capabilities and limitations of wearable medical devices used to support clinical decision-making. Such report shall include a description ofโ€” (1) the potential for such devices to accurately prescribe treatments; (2) an examination of the benefits and challenges of artificial intelligence to augment such capabilities; and (3) policy options to enhance the benefits and mitigate potential challenges of developing or using such devices.